TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay July 17, 2009
TCL Archive Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89 July 17, 1987
TCL Archive Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture February 25, 2011
